Vireo Growth (VREOF) Receivables - Other (2021 - 2024)

Vireo Growth (VREOF) reported Receivables - Other of $174660.0 for Q4 2024, little changed on a YoY basis from $174660.0 in Q1 2024, and down 96.66% sequentially from $5.2 million in Q3 2024.

Vireo Growth (VREOF) Receivables - Other (2021 - 2024) Analysis & Trends

Vireo Growth (VREOF) has 3 years of Receivables - Other data on file, last reported at $174660.0 in Q4 2024.

  • For the quarter ending Q4 2024, Receivables - Other changed 0.0% year-over-year to $174660.0; the trailing twelve-month figure through Dec 2024 stood at $174660.0 (changed 0.0% YoY), and the FY2024 full-year result was $174660.0, changed 0.0% from the prior year.
  • Receivables - Other eased to $174660.0 in Q4 2024, from $5.2 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $5.2 million in Q3 2024 to a low of $174660.0 in Q4 2023.
  • A 3-year average of $2.1 million and a median of $1.4 million in 2023 frame the typical range for Receivables - Other.
  • Peak annual rise in Receivables - Other reached 289.97% in 2024, while the deepest fall reached 0.0% in 2024.
  • Tracing VREOF's Receivables - Other over 3 years: stood at $191026.0 in 2021, then fell by 8.57% to $174660.0 in 2023, then changed by 0.0% to $174660.0 in 2024.
  • Business Quant data shows VREOF's Receivables - Other at $174660.0 in Q4 2024, $5.2 million in Q3 2024, and $4.9 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Dec 31, 2024 174,660.00
Dec 31, 2024 174,660.00
Sep 30, 2024 5.22 Mn
Sep 30, 2024 5.22 Mn
Jun 30, 2024 4.87 Mn
Jun 30, 2024 4.87 Mn
Mar 31, 2024 3.27 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 174,660.00
Dec 31, 2023 174,660.00
Sep 30, 2023 1.57 Mn
Sep 30, 2023 1.57 Mn
Jun 30, 2023 1.25 Mn
Jun 30, 2023 1.25 Mn
Dec 31, 2021 191,026.00
Dec 31, 2021 191,026.00